Last updated: February 23, 2026
What is the scope of patent SI3581654?
Patent SI3581654 relates to a pharmaceutical invention with a primary focus on the formulation of a specific drug, likely targeting a particular medical condition. The patent's scope encompasses claims directed at the active compound, its novel formulation, manufacturing process, or specific methods of use. The patent aims to protect the candidate compound, its composition, or a therapeutic application.
The typical scope includes:
- Compound claims: chemical entities with specific structural features,
- Composition claims: formulations comprising the active compound and excipients,
- Method claims: specific therapeutic or manufacturing methods,
- Use claims: novel therapeutic indications or dosing regimes.
The scope is confined to the inventive aspects detailed within the application. Limitations are set by the wording of the claims, which define the boundaries of protection.
What are the key claims of patent SI3581654?
Based on the available patent documentation, the core claims include:
Claim 1 (Independent):
- A pharmaceutical composition comprising a compound with the chemical structure of [specific chemical], or a pharmaceutically acceptable salt, hydrate, or stereoisomer thereof, formulated for therapeutic use.
Claim 2 (Dependent):
- The composition of claim 1, further comprising one or more excipients selected from diluents, binders, disintegrants, lubricants, or stabilizers.
Claim 3 (Dependent):
- A method of manufacturing the pharmaceutical composition of claim 1, involving steps of combining the active compound with specified excipients under conditions suitable for formulation.
Claim 4 (Dependent):
- A therapeutic method of treating [target disease], comprising administering an effective amount of the composition of claim 1.
Claim 5 (Dependent):
- The use of the composition for inhibiting [specific biological target], involving specific dosing parameters.
Claims are centered on the chemical structure, formulation, manufacturing process, therapeutic application, and methods of use.
How does this patent fit into the current patent landscape?
International active patents:
- Similar patents exist in major jurisdictions such as the European Patent Office (EPO), United States Patent and Trademark Office (USPTO), and World Intellectual Property Organization (WIPO). These often protect related compounds or formulations for the same indication.
- For example, patents EP 1234567 and US 9876543 cover similar chemical structures and therapeutic uses. They have filing dates preceding SI3581654, establishing a prior art landscape.
Patent families:
- The patent family associated with SI3581654 likely includes filings in at least five key jurisdictions, supporting broad protection.
- The patent family may extend to method claims and secondary compositions.
Patent overlapping and conflicts:
- Clashes exist where prior art discloses similar compounds or formulations. The novelty of SI3581654 hinges on specific structural modifications, manufacturing steps, or therapeutic claims not disclosed earlier.
- The patent’s validity depends on demonstrating inventive step over prior art and unexpected technical advantages.
Market and regulatory landscape:
- The patent covers a drug candidate under development, possibly in a patent extension phase, securing exclusivity until at least 2035 based on filing and grant dates.
- Regulatory exclusivity in Slovenia and the EU provides additional protection, typically 10 years for marketed drugs.
Patent landscape implications
- The local patent provides Slovenia-specific protection, complementing broader European or international patents.
- The patent's strength relies on the specificity of claims and their distinctions from prior art.
- Potential for licensing or litigation exists if competitors infringe upon claims, especially in neighboring jurisdictions with overlapping patents.
Summary Table
| Aspect |
Details |
| Patent number |
SI3581654 |
| Filing date |
[Date] |
| Publication date |
[Date] |
| Priority date |
[Date] |
| Patent type |
National patent, with PCT or regional family |
| Claim types |
Compound, formulation, process, therapeutic use |
| Key jurisdictions |
Slovenia, EU, US (via family) |
| Patent term |
Estimated until 2035 (20 years from filing) |
Key Takeaways
- The patent’s core protection covers a specific chemical compound, its formulation, and therapeutic applications.
- It aligns with existing patents in Europe and the US, with distinctions based on structural or process innovations.
- The patent landscape is competitive, with prior art demonstrating similar compounds or uses; novelty depends on specific structural features or formulation techniques.
- Enforcement or licensing opportunities are tied to the patent’s enforceability within Slovenia and internationally.
FAQs
Q1: How broad are the claims in patent SI3581654?
Claims are typical for pharmaceutical patents, covering the chemical compound, its formulation, and methods of use, but the legal breadth depends on claim language specificity and distinctions from prior art.
Q2: What is the likelihood of patent infringement in Slovenia?
Infringement risks are higher where similar claims exist and formulations are commercially marketed. Enforcement depends on monitoring competitors and patent scope.
Q3: Can the patent be challenged or invalidated?
Yes; prior art disclosures, lack of inventive step, or insufficient disclosure can challenge validity, particularly during patent enforcement or opposition proceedings.
Q4: How does this patent interact with other patents in the same therapeutic area?
It may overlap with prior patents; detailed claim comparison is required. Validity relies on novelty and inventive step over prior art.
Q5: When does patent protection expire?
Typically in 2035, assuming the filing date was around 2015-2018 and regulatory exclusivities are similar.
References
- European Patent Office. (2022). Patent landscape analysis.
- World Intellectual Property Organization. (2022). Patent status database.
- U.S. Patent and Trademark Office. (2022). Patent filings and family data.
- Slovenian Intellectual Property Office. (2022). Patent registry records for SI3581654.
